Carenation
PrivateLast Round
Series B
Extension
Jan 17, 2024
Est. Valuation
$75.19M
Total Funding Raised
$25.3M
Company Overview
Carenation operates in Healthcare & Life Sciences and is based in Seoul. Its latest recorded funding round was a Series B Extension round in January 2024.
Carenation is a healthcare technology company that operates an integrated care platform connecting patients with caregivers, including nursing assistants and postpartum helpers.
Sector
Healthcare & Life Sciences
Verticals
Vertical SaaS, E-commerce
Business Model
B2B2C
Customer Profile
Marketplace Commission, Subscription SaaS, Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Carenation Comparables
Compare Carenation with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Bosalpim | 85% | |
| Caring | 84% | |
| Code Blossom | 84% |
For institutional investors. Book with your work email.
Carenation Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B Extension | Jan 17, 2024 | ||||
| Debt | Jul 6, 2022 | ||||
| Early Funding | Nov 25, 2021 | ||||
| Series A | Mar 24, 2020 |
For institutional investors. Book with your work email.
Carenation Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Hana Ventures | Series B Extension, Early Funding, Series A |
| DAYLI Partners | Debt |
| Saehan Ventures | Early Funding |
| Samsung Venture Investment | Series B Extension, Early Funding |
| ROWE Partners | Seed |
| HB Investment | Early Funding, Seed, Series A |
| LSK Investment | Early Funding, Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 6, 2022
$1.54M debt round led by DAYLI Partners.
- Nov 25, 2021
$14M raised from Samsung Venture Investment and others.
For institutional investors. Book with your work email.
Carenation Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Carenation's valuation, stock price, and market status.
Is Carenation a public or private company?
Carenation is a private company.
What is the current stock price of Carenation?
Carenation is a private company, so its shares have no public market price. Caplight tracks Carenation's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Carenation worth (valuation)?
Carenation's valuation is estimated at $75.2M based on funding round data.
Can I buy Carenation stock?
Carenation shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Carenation's last funding round?
Carenation's most recent funding round was Series B Extension on January 17, 2024.
Who are the main investors in Carenation?
Key investors in Carenation include Hana Ventures, DAYLI Partners, Saehan Ventures, Samsung Venture Investment, ROWE Partners.
Will Carenation IPO soon?
No public IPO plans have been announced for Carenation.
How can I track Carenation secondary market activity?
Caplight tracks bids, offers, and trades in Carenation's shares on secondary markets.